INS and type 1 diabetes mellitus: In this cohort study of Colorado’s insulin copayment cap among individuals with type 1 diabetes, our results suggest that the policy targeting and imposing caps on out-of-pocket spending for insulin was associated with declines in out-of-pocket spending and improved treatment adherence and health outcomes, but mostly for individuals with prepolicy spending levels above the cap.